Abstract Background and Objective Various extrapulmonary effects and comorbidities have been noted to contribute to the burden of chronic obstructive pulmonary disease (COPD). However, the relationship between the prevalence of COPD and non-respiratory diseases has not been well investigated. The aim of the present study was to determine whether or not COPD is different among patients already suffering from other diseases.
Introduction
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality (1) . Recently, the high worldwide prevalence of COPD has been reported to be more than 9% in Europe (2) , more than 11% in Latin America (3) , and 8.6% in Japan (4) . In addition, new aspects of COPD, such as systemic consequences and comorbidities, have received attention (5) (6) (7) . It has been reported that up to 25% of the population older than 65 years suffers from two comorbid conditions and up to 17% have three (8) .
Because COPD often develops in long-time smokers in middle age, patients often have a variety of other diseases related to either smoking or aging (9) . In contrast, systemic consequences may be secondary to the lung disease, probably via the release of inflammatory mediators/cytokines from the lung into the systemic circulation (6, 10) . Muscle wasting in COPD patients is probably one of the best known systemic features, and this may be due to the effects of cytokines from the lungs on skeletal muscle (11, 12) 
Methods

Subject recruitment
The study was conducted in patients who visited 9 (Fig. 2) . (Fig. 3) 
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T a b l e 1 . Ch a r a c t e r i s t i c s o f t h e E l i g i b l e S u b j e c t s the type of disease, it was high in liver diseases (18.8%), diabetes mellitus (11.7%), cardiovascular diseases (11.3%), and cerebrovascular diseases (11.1%)
Discussion
In the present study, we showed that COPD was newly found in as many as 10.3% of the patients in primary care clinics who were 40 years or older and had various non-
T a b l e 2 . Ch a r a c t e r i s t i c s o f COP D P a t i e n t s
F i g u r e 3 . T h e p r e v a l e n c e o f COP D a c c o r d i n g t o e a c h t y p e o f d i s e a s e . T h e p r e v a l e n c e o f COP D wa s t h e h i g h e s t i n t h e p a t i e n t s wi t h l i v e r d i s e a s e s .
respiratory diseases. We also showed that there were differences in the prevalence of COPD among the patients with other diseases for the first time. In particular, the patients with liver diseases had a significantly higher prevalence of COPD when the odds ratio was adjusted by the amount of smoking and age. (18, 19) , lung growth (20) , gender (21, 22) , socioeconomic status (23) and nutrition (24) . Furthermore, recently, it has been reported that systemic inflammation could be involved in the pathogenesis of COPD (5) (6) (7) , and that COPD patients are at increased risk for several comorbidities including myocardial infarction, osteoporosis, depression and diabetes (1) . However, it is still unclear whether such diseases affect the prevalence of COPD. Therefore, it could be important to clarify the correlation between the prevalence of COPD and the other diseases. In the present study, we demonstrated that patients with liver disease had a high prevalence of COPD.
Smoking is a major risk factor for COPD and aging increases the prevalence of COPD. Other possible reported risk factors include genetic factors
It has been reported that chronic HCV infection may have adverse effects on pulmonary function in patients with COPD and asthma. The rates of annual decline in FEV1 and diffusing capacity for carbon monoxide in COPD patients were significantly higher in HCV-positive patients than in HCV-negative patients (25) . These declines were also higher in HCV-positive asthmatic patients than in HCV-negative and interferon responding asthmatic patients (26 (27, 28) , and that the IL-8 levels are associated with HCV replication (29) . The enhanced production of IL-8 is induced via transcriptional ac-T a b l e 3 . P r e v a l e n c e o f COP D Ad j u s t e d b y t h e Amo u n t o f S mo k i n g a n d Ag e T a b l e 4 . P r e v a l e n c e o f COP D a n d De t a i l s o f L i v e r Di s e a s e s tivation and mRNA stabilization (27) . An elevation of the serum level of IL-8 has also been observed in patients with nonalcoholic steatohepatitis (30) and those with alcoholic liver disease (31) (1, 32) . It has been reported that the exhaled NO level is increased in liver cirrhosis (33, 34) , and the expression of pulmonary vascular NO synthase (NOS) is increased in hepatopulmonary syndrome (35) (36) (37) 
